Can an ultrasound predict who can skip surgery for rectal cancer?

NCT ID NCT03068403

Terminated Diagnosis Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study tested whether a special ultrasound technique (D-CEUS) can predict how well rectal cancer responds to chemotherapy and radiation. The goal is to identify good responders who might avoid major surgery and instead have a less invasive procedure. Only 2 people took part, making this a very early exploration.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dynamic contrast-enhanced ultrasound (D-CEUS) with Sonovue contrast agent
What this could lead to: If successful, this imaging method could help identify rectal cancer patients who respond well to chemoradiation, allowing them to avoid major surgery.
What could go wrong: This was a very small early study with only 2 participants, so results may not apply to larger groups. The technique is still experimental and needs much more testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal carcinoma rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECTAL CANCER

Contacts and locations

Locations

CHU de Bordeaux

Bordeaux, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.